Therapy Areas: Vaccines
12 November 2025 - Biotechnology company Anixa Biosciences Inc (NASDAQ: ANIX) announced on Wednesday that the United States Patent and Trademark Office will issue U.S. Patent No. 12,472,205 on 18 Nove...
12 November 2025 - Danish clinical-stage biotechnology company ExpreS2ion Biotechnologies ApS, an affiliate of ExpreS2ion Biotech Holding AB (STO: EXPRS2), announced on Wednesday that it has signed a ...
7 November 2025 - PharmaJet®, a leader in needle-free drug delivery systems designed to improve outcomes and patient comfort, has confirmed a new Distribution Agreement with ATR, an affiliate comp...
5 November 2025 - Lunai Bioworks (NASDAQ: LNAI), an AI-powered drug discovery and biodefence company, on Wednesday announced the publication of a landmark study detailing its second-generation allogen...
3 November 2025 - Frontier IP Group plc (AIM: FIPP) announced on Monday that its portfolio company The Vaccine Group has achieved outstanding results in cattle challenge trials for two vaccine candida...
3 November 2025 - South Korean pharmaceutical company GC Biopharma (KRX:006280) announced on Monday that the Phase 2 clinical trial results for its anthrax vaccine 'BARYTHRAX inj. (GC1109)' ...